top of page
  • White Facebook Icon
  • White Instagram Icon
  • White Twitter Icon
  • White LinkedIn Icon
ISU_LOGO_ENG.png

Advancements in CAR-T Cell Therapy: Innovations and Current Challenges in Clinical Applications

UPENN-ISU & Liv Hospital Group Joint Program

16,17 January 2026

ISTANBUL, TURKEY

The Speakers

04

CART THERAPHY EXPERTS

Jack Ende, MD

Upenn Medicine, Internal medicine

01

Ende_Jack.jpg

Marco Ruella, MD

UPenn Medicine Hematology Oncology

ruella_marco.jpg

Carl H. June, MD

Upenn Pathology and Laboratory Medicine

David L Porter UPENN.jpg

David L. Porter, MD

Upenn Medicine Hematology - Oncology

Carl June UPENN.jpg

Alfred Garfall, MD

Upenn Hematology - Oncology

Garfall-Alfred_web_SQ.jpg

Jonas Tanyi, MD, PhD

Upenn Gynecologic Oncology

tany9089.jpg

02

Meral Beksaç, MD

Liv Hospital Hematology Specialist

0e37b765-ecce-44f0-9991-f19035fa4b7a_meralBeksac_edited.png

Mehmet Hilmi Doğu, MD

Liv Hospital Hematology Specialist

mehmet-hilmi-dogu-gematolog-turcziya-1_e

Itır Şirinoğlu Demiriz, MD

03

Liv Hospital Hematology Specialist

Itır Şirinolu Demiriz_edited.jpg

Erdal Karaöz, PhD

Director of Liv Hospital Vadistanbul Cellular Therapy Program

Prof-PhD-Erdal-Karaoz.jpg

Tülin Tiraje Celkan, MD

Liv Hospital

Pediatric Hematology and Oncology specialist

Tülin Tiraje Celkan.png

Tunç Fışgın, MD

MedicalPark Hospital

Pediatric Hematology and Oncology

tunc-fisgin.jpg

Başak Adaklı Aksoy, MD

MedicalPark Hospital

Pediatric Hematology and Oncology

Başak adaklı aksoy.jpg

Fatma Visal Okur, MD

Pediatric Hematology and Oncology specialist

Fatma Visal Okur.jpg

04

Koray Yalçın,MD

MedicalPark Hospital

Pediatric Hematology and Oncology

Koray Yalçın.jfif

Özgür Tataroğlu, PhD

Business Director, Liv Hospital Vadistanbul Cellular Therapy Program

Ozgur-Tataroglu.png

Ayca İlter Tataroğlu, PhD

Scientific Director, Liv Hospital Vadistanbul Cellular Therapy Program

Ayca-Ilter.png
Speakers

Agenda - Day 1

16 January 2026

08:00 - 09:00

09:00 - 09:15

Registration & Welcome Coffee 

Opening Speech - Meri Istiroti, Jack Ende, MD & Itır Demiriz, MD

Session 1

Hematology – Leukemia - Jack Ende, MD & Meral Beksaç, MD

09:15-10:00

Acute and Chronic Leukemia | David Porter, MD

10:00-10:45

Lymphomas | Marco Ruella, MD

10:45-11:30

Multiple Myeloma | Alfred Garfall, MD

11:30-11:45

Coffee Break & Networking 

11:45-12:30

Multiple Myeloma | - Meral Beksaç, MD - European Myeloma Network

12:30-14:00

Lunch Break 

14:00-14:45

CAR-T Cell Therapy and New Approaches | Carl H June, MD(Virtual attendance)

Session 2

Pediatric  - Session Chairs - Prof. Tülin Tıraje Celkan, MD & Prof. Tunç Fışgın, MD

14:45-15:15

General approach to Car-T Applications in Pediatrics – Fatma Visal Okur, MD

15:15-15:45

Car-T Cell treatments in ALL patients  – Koray Yalçın, MD

15:45-16:15

Coffee Break & Networking

16:15-16:45

Car-T Cell applications in Solid Tumors – Başak Adaklı Aksoy, MD

16:45-17:00

Panel Discussion & Q&A

17:00-17:30

Experts’ Insights & Open Forum for Discussion

Agenda - Day 2

17 January 2026

Session 1 – Complications and Toxicities panel chairs: Mehmet Hilmi Doğu, MD & David Porter, MD

09:00-09:45

New evidence in the pathogenesis of Car-T toxicities and future strategies to overcome them  - Marco Ruella, MD

09:45-10:30

Car-T toxicities: Crs, Icans but also delayed neurotoxcity, Secondary Malignancies, Cardiac Complications, Infections and Prophylaxis – Alfred Garfall, MD

10:30-10:45

Coffee Break & Networking

Session 2 – New areas chairs: Marco Ruella, MD & Itır Şirinoğlu Demiriz, MD 

10:45-11:15

Car-T for solid tumors from the lab to the clinic: The UPENN experıence - Janos Tanyi, MD, PhD

11:15-11:45

Autoimmune Disease Disorders: The new frontiers for Car-T – David Porter, MD

11:45-12:30

Lunch Break

Session 3 – Liv Hospital CAR-T Program 

12:30-13:00

Liv Hospital Vadi CAR-T Manufacturing Facility - Özgür Tataroğlu, PhD

13:00-13:30

CAR-T Cell Therapy Program at Liv Hospital Vadi - Ayca İlter Tataroğlu, PhD

Panel Discussion & Q&A

13:30-14:15

Experts’ Insights & Open Forum for Discussion 

Closing Remarks & Certificates Distribution

Agenda
WhatsApp Image 2025-07-02 at 10.43.34.jpeg
Liv Vadi.jpg

The Venue

Liv Hospital Vadi Conference Hall

The Liv Hospital Vadi Conference Hall offers a sophisticated and versatile venue perfect for a wide range of corporate and medical events. Located within the esteemed Liv Hospital Vadiistanbul, our modern facility is designed to host productive and engaging gatherings.

With a comfortable capacity for 150 attendees, the main hall provides an ideal setting for conferences, seminars, workshops, and presentations. Beyond the main auditorium, you'll find a spacious foyer area, perfect for registration, coffee breaks, and networking. This welcoming space also provides ample room for companies to set up exhibition stands, offering excellent opportunities for showcasing products, services, or research in a professional environment.

02

17

120

DAY
SPEAKERS
PARTICIPANTS
The Venue

Our sponsors and Key partners

UniversityofPennsylvania_FullLogo_RGB-4_0_edited.jpg
WhatsApp Image 2024-09-18 at 11.37.24.jpeg
istinye-university-logo.png
Contact

Advancements in CAR-T Cell Therapy: Innovations and Current Challenges in Clinical Applications

UPENN-Liv Hospital Group Joint Program

What

Advancements in CAR-T Cell Therapy: Innovations and Current Challenges in Clinical Applications

Where

Liv Hospital Vadistanbul Conference Hall

When

16th and 17th of January 2026

Contact Us

To learn more, don’t hesitate to get in touch

0090 530 173 06 93 - Available for whatsapp

  • Facebook
  • Instagram
  • Twitter
  • LinkedIn

© 2025 by TIC. Powered and secured by Liv Academy of Liv Hospital Group

bottom of page